Abacavir (Ziagen)

Conference Coverage

The Latest

Reducing Risk of Myocardial Infarction in HIV-Positive People Img

Reducing Risk of Myocardial Infarction in HIV-Positive People

This year at CROI 2018 a few studies tried to explore possible mechanisms for the association of increased myocardial infarction risk and abacavir use.

Promo Image

What 2014 Development Has the Biggest Impact on HIV Care?

Each year we see new developments in HIV that improve the lives of those living with the disease and make it easier for providers to care for patients. We asked some of the leading experts what development this year they thought would have the biggest …

Promo Image

What's Hot in HIV Treatment

Here’s a recap of the biggest developments in HIV treatment over the past year, as well as a look at what’s to come.

Abacavir Link to Cardiovascular Events in High-Risk Patients Maintained in D:A:D Study Img

Abacavir Link to Cardiovascular Events in High-Risk Patients Maintained in D:A:D Study

A poster at CROI 2014, presented by Caroline Sabin from University College London and colleagues, presented follow-up results from D:A:D since the initial findings in 2008 of a link between abacavir use and risk of myocardial infarction (MI) in peopl...

Promo Image

FDA Report Suggests Abacavir May Not Increase Myocardial Infarction Risk After All

In a poster that was presented on March 2 at the 18th Conference on Retroviruses and Opportunistic Infections (CROI 2011), the U.S. Food and Drug Administration (FDA) reported that it has found no evidence of an association between abacavir (ABC, Zia...

Promo Image

More Patients With High Viral Loads Experience Virologic Failure When Starting Therapy With an Abacavir-Based Regimen Than a Tenofovir-Based Regimen

My name is Paul Sax. I'm the clinical director of the HIV program at Brigham and Women's Hospital in Boston, and an associate professor of medicine at Harvard Medical School. Today I presented the results of the ACTG 5202 study comparing tenofovir/FT...

Promo Image

Switching Due to Lipoatrophy: Tenofovir Bests Abacavir in Tolerability, Lipid Profile

Abacavir (ABC, Ziagen) or tenofovir (TDF, Viread): Which is a better bet when attempting to help alleviate the lipoatrophy experienced by patients who are taking stavudine (d4T, Zerit) or zidovudine (AZT, Retrovir)? The latest RAVE study results show...

Promo Image

Severity and Rate of Abacavir Hypersensitivity Reactions Higher Than Previously Believed

The recent availability in the United States and Europe of new fixed-dose combinations of the previously approved nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) abacavir/lamivudine (ABC/3TC, Epzicom, Kivexa) and tenofovir/emtricitabin...